Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Importance of "Clinical Mind" Stressed: JASDI Forum
January 30, 2006
- Chugai: Sales Up 11%, Profits Up 57.2%
January 30, 2006
- PI Study on Nanoplatin Approved in UK: NanoCarrier
January 30, 2006
- MCHC to Aim at Fusion of Pharmaceuticals and Diagnostics
January 30, 2006
- 3 Major DDS Preparations under Development by LTT Bio-Pharma
January 30, 2006
- Sankyo, Daiichi to Collaborate in Marketing 2nd Product
January 30, 2006
- Takeda Enters PII for the Anti-obesity Drug ATL-962 in Japan
January 30, 2006
- AMO to Focus on the Vision Care Life Cycle
January 30, 2006
- PHARMA DELEGATES
January 30, 2006
- NEW PRODUCTS
January 30, 2006
- PhRMA Announces Mr Ira Wolf as New Japan Representative
January 30, 2006
- REGULATORY NEWS IN BRIEF
January 30, 2006
- Early Approval of 4 Products Urged by Council
January 30, 2006
- Gaps Remain in Participation of Joint-stock Companies in Medical Services
January 30, 2006
- Outline of FY2006 Medical Fee Revision Approved by Chuikyo
January 30, 2006
- Nichi-iko to Make 108 GE Drugs Available in All Specifications
January 30, 2006
- Original and Generic Drugs "Not Bioequivalent": Prof. Masada
January 30, 2006
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
January 30, 2006
- Chuikyo Recommends Replacement of Current Prescription Form
January 30, 2006
- Josai Clinic Provides Comprehensive Care for Hair Loss
January 30, 2006
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…